| 4-Methoxy-N-(2,4,6-triMethylphenyl)benzenesulfonaMide, 97% |
4-甲氧基-N-(2,4,6-三甲基苯)苯磺酰胺 |
349085-82-1 |
| 5'-ISOBUTYLTHIO-5'-DEOXYADENOSINE |
5ˊ-异丁硫基-5ˊ-脱氧腺苷 |
35899-54-8 |
| 2-CHLORO-N,6-DIMETHYL-4-PYRIMIDINAMINE |
2-氯-N,6-二甲基-4-嘧啶胺 |
3569-33-3 |
| 1,1,1-TRIFLUORO-2-PROPANOL |
1,1,1-三氟异丙醇 |
374-01-6 |
| 4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]- |
VIT-2763 |
2095668-10-1 |
| Deltasonamide 2
(Deltasonamide2) |
DELTASONAMIDE 2 |
2088485-34-9 |
| TN1 |
289479-94-3 |
289479-94-3 |
| TH34 |
CS-2858 |
2196203-96-8 |
| AT-130
(AT130) |
AT-130
(AT130) |
211364-06-6 |
| PF-04965842(Abrocitinib) |
PF-04965842(阿布罗替尼) |
1622902-68-4 |
| Benzeneacetic acid, 4-[[2-(3-chlorophenyl)-6-(trifluoromethyl)-4-pyridinyl]methyl]- |
BPN14770 |
1606974-33-7 |
| Cav 2.2 blocker 1 |
CAV 2.2 BLOCKER 1 |
1567335-29-8 |
| PFE-360 |
PFE-360 |
1527475-61-1 |
| BQR695 |
BQR695 |
1513879-21-4 |
| Thieno[3,2-d]pyriMidine-6-carboxaMide, 4-[4-[2-[(Methylsulfonyl)aMino]ethyl]-1-piperidinyl]- |
4-[4-[2-[(METHYLSULFONYL)AMINO]ETHYL]-1-PIPERIDINYL]-THIENO[3,2-D]PYRIMIDINE-6-CARBOXAMIDE |
1431411-66-3 |
| IDF-11774 |
无中文名称 |
1429054-28-3 |
| Mutant IDH1 inhibitor |
(4S)-3-[2-[[(1S)-1-[4-[(4-乙酰基-1-哌嗪基)甲基]苯基]乙基]氨基]-4-嘧啶基]-4-异丙基-2-恶唑烷酮 |
1429180-08-4 |
| ML198 |
化合物ML198 |
1380716-06-2 |
| USP7-IN-1 |
1381291-36-6 |
1381291-36-6 |
| 2-Pyridinamine, 3-[(1S)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]- |
(S)-CRIZOTINIB |
1374356-45-2 |
QQ
微信
